ꢀ
Concellon et al.
JOCNote
explain the relative configuration of olefins obtained by other
SmI2-promoted elimination reactions.
filtered, and concentrated under reduced pressure. Flash chro-
matography on silica gel (hexane/EtOAc 3:1) afforded pure
(E)-R,β-unsaturated amides 4.
In conclusion, we have demonstrated that the sama-
rium enolate formed from dichloroacetamide can be easily
prepared and employed in the synthesis of unmasked (E)-R,β-
unsaturated primary amides. These compounds are obtained
with complete E-stereoselectivity through a sequential two-
step process: an aldol-type and a β-elimination reaction.
(E)-2-Decenamide (4a). 1H NMR (300 MHz, CDCl3) δ 6.86
(dt, J=15.2. 6.9 Hz,1 H), 5.82 (d, J=15.2 Hz, 1 H), 5.43 (br s,
2 H), 2.22-2.15 (m, 2 H), 2.03-1.18 (m, 10 H), 0.78 (t, J =
6.5 Hz, 3 H); 13C NMR (75 MHz, CDCl3) δ 168.1 (C), 146.6
(CH), 122.5 (CH), 32.0 (CH2), 31.7 (CH2), 29.0 (2ꢀCH2), 28.1
(CH2), 22.5 (CH2), 14.0 (CH3); MS (70 eV, EI) m/z (%) 151
([M - H2O]þ, 1), 122 (40), 98 (91), 72 (89), 59 (100); HRMS
(70 eV) calcd for [C10H19NO] 169.1467, found 169.1468; IR
(neat) 3387, 1680, 1258 cm-1; Rf=0.25 (hexane/EtOAc 1:2).
(E)-4-Methyl-2-hexenamide (4b). 1H NMR (300 MHz,
CDCl3) δ 6.74 (dd, J=15.3, 7.7 Hz, 1 H), 5.78 (dd, J=15.3,
3.0, Hz, 1 H), 5.60 (br s, 2 H), 2.22-2.17 (m, 1 H), 1.41-1.37
Experimental Section
Preparation of 2-Chloro-3-hydroxyamides (3). To a stirred
suspension of aldehyde 1 (0.4 mmol), dichloroacetamide 2
(0.4 mmol), and samarium powder (1 mmol) in THF (10 mL)
was added CH2I2 (1 mmol) dropwise at room temperature, and
the mixture was stirred for 3.5 h. The excess of SmI2 was
removed by bubbling a stream of air through the solution.
The crude reaction material was washed with 0.1 N (aq) HCl
(10 mL) and was extracted with DCM (3 ꢀ 10 mL). The
combined organic layers were dried over anhydrous Na2SO4,
filtered, and concentrated under reduced pressure. Flash chro-
matography on silica gel (hexane/EtOAc 3:1) afforded pure
chlorohydrines 3.
(m, 2 H), 1.03 (d, J=6.5 Hz, 3 H), 0.87 (t, J=7.3 Hz, 3 H); 13
C
NMR (75 MHz, CDCl3) δ 168.2 (C), 151.6 (CH), 121.0 (CH),
37.9 (CH), 28.8 (CH2), 19.0 (CH3), 11.6 (CH3); MS (ESIþ) m/z
(%) 127 ([M]þ, 27), 112 (100), 98 (24), 83 (18), 70 (22), 57 (24);
HRMS (ESIþ) calcd for [C7H14NO]þ [M þ H]þ 128.1075, found
128.1070; IR (neat) 3406, 1676, 1458, 1266 cm-1; Rf = 0.32
(EtOAc).
(E)-3-Cyclohexylacrilamide (4c). 1H NMR (300 MHz,
CDCl3) δ 6.80 (dd, J=15.5, 6.8 Hz, 1 H), 5.76 (d, J=15.5 Hz,
1 H), 5.53 (br s, 2 H), 2.16-2.04 (m, 1 H), 1.97-1.65 (m, 5 H),
1.31-1.08 (m, 5 H); 13C NMR (75 MHz, CDCl3) δ 166.7 (C),
151.5 (CH), 120.1 (CH), 40.2 (CH), 31.8 (2ꢀCH2), 25.9 (CH2),
25.7 (2ꢀCH2); MS (70 eV, EI) m/z (%) 153 ([M]þ, 100), 136 (50),
109 (35); HRMS (ESIþ) calcd for [C9H16NO]þ [M þ H]þ
2-Chloro-3-hydroxydecanamide (3a). 1H NMR (300 MHz,
CDCl3) δ 6.69 (br s, 1 H), 6.60 (br s, 1 H), 6.22 (br s, 1 H),
6.13 (br s, 1 H), 4.35 (d, J=2.3 Hz, 1 H), 4.26 (d, J=5.7 Hz, 1 H),
4.20-4.16 (m, 1 H), 4.06-4.00 (m, 1 H), 3.30 (br s, 1 H), 2.81
(br s, 1 H), 1.67-1.46 (m, 4 H), 1.42-1.17 (m, 20 H), 0.86 (t, J=
6.3 Hz, 6 H); 13C NMR (75 MHz, CDCl3) δ 171.0 (C), 170.7 (C),
72.8 (CH), 71.9 (CH), 63.6 (CH), 62.3 (CH), 33.6 (CH2), 32.9
(CH2), 31.7 (2ꢀCH2), 29.3 (CH2), 29.2 (CH2), 29.0 (2ꢀCH2),
25.5 (CH2), 25.2 (CH2), 22.5 (2 ꢀ CH2), 14.0 (2 ꢀ CH3); MS
(70 eV, EI) m/z (%) 186 ([Mþ - Cl], 12), 122 (23), 95 (33), 93
(100), 55 (40); HRMS (70 eV) calcd for [C10H20ClNO2 - H2O]
154.1231, found 154.1226; IR (neat) 3363, 1676, 1406 cm-1
;
Rf=0.50 (EtOAc).
(E)-5-Phenyl-2-pentenamide (4d). 1H NMR (300 MHz, CDCl3)
δ 7.50-7.08 (m, 5 H), 6.91 (dt, J=15.3, 6.9 Hz, 1 H), 5.85 (d, J=
15.3 Hz 1 H), 5.56 (br s, 2 H), 2.79 (t, J=7.7 Hz, 2 H), 2.54 (c, J=
7.3 Hz, 2 H); 13C NMR (75 MHz, CDCl3) δ 167.7 (C), 145.1
(CH), 140.8 (C), 128.5 (2xCH), 128.4 (2ꢀCH), 126.1 (CH), 123.1
(CH); 34.4(CH2), 33.7 (CH2); MS(70eV, EI) m/z (%) 175 ([M]þ,
2), 130 (9), 91 (100), 77 (3), 44 (5); HRMS (ESIþ) calcd for
[C11H14NO]þ [M þ H]þ 176.1075, found 176.1070; IR (neat)
3435, 1643, 1453, 1265 cm-1; Rf=0.35 (hexane/EtOAc 1:5).
203.1077, found 203.1086; IR (neat) 3383, 1663, 1081, 723 cm-1
;
Rf=0.30 (hexane/EtOAc 1:1).
2-Chloro-3-cyclohexyl-3-hydroxypropanamide (3b). 1H NMR
(300 MHz, CDCl3) δ 6.66 (br 1 H), 6.64 (br 1 H), 5.34 (apparent
s, 1 H), 5.08 (dd, J=8.2, 6.7 Hz, 1 H), 1.91-0.90 (m, 11 H); 13
C
NMR (75 MHz, CDCl3) δ 164.7 (C), 78.5 (CH), 66.2 (CH), 42.1
(CH), 29.6 (CH2), 27.8 (CH2), 26.0 (CH2), 25.5 (2ꢀCH2); MS (70
eV, EI) m/z (%) 187 ([Mþ-H2O], 15), 186 (100), 150 (79), 93 (15),
79 (20), 67 (10); HRMS (70 eV) calcd for [C9H16ClNO2 - H2O]
1
(E)-5,7,7-Trimethyl-2-octenamide (4e). H NMR (300 MHz,
CDCl3) δ 6.90-6.80 (m, 1 H), 5.84 (dt, J=16.4, 1.5 Hz, 1 H),
5.54 (br s, 2 H), 2.16-2.14 (m, 1 H), 2.08-2.0 (m, 1 H),
1.98-1.64 (m, 2 H), 1.07 (dd, J=14.0, 6.5 Hz, 1 H), 0.94 (d,
J=6.5 Hz, 3 H), 0.89 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ
167.8 (C), 145.4 (CH), 123.7 (CH), 50.5 (CH2), 41.8 (CH2), 31.0
(C), 29.9 (3ꢀCH3), 29.0 (CH), 22.4 (CH3); MS (ESIþ) m/z (%)
184 ([MþH]þ, 100), 142 (3), 128 (2), 102 (1); HRMS (ESIþ) calcd
for [C11H22NO]þ [M þ H]þ 184.1701, found 184.1696; IR (neat)
3055, 1686, 1422, 1264 cm-1; Rf=0.35 (hexane/EtOAc 1:2).
(2E,9Z)-Dodeca-2,9-dienamide (4f). 1H NMR (300 MHz, CDCl3)
δ 6.85 (dt, J=15.3, 6.9 Hz, 1 H), 5.81 (d, J=15.3, 1 H), 5.58 (br s,
2 H), 5.40-5.25 (m, 2 H), 2.22-2.15 (m, 2 H), 2.07-1.96 (m, 4 H),
1.47-1.25 (m, 6 H), 0.95 (t, J=7.5 Hz, 3H); 13C NMR (75 MHz,
CDCl3) δ 167.9 (C), 146.4 (CH), 131.7 (CH), 128.9 (CH), 122.6
(CH), 31.9 (CH2), 29.4 (CH2); 28.7 (CH2), 28.0 (CH2), 26.8 (CH2),
20.4 (CH2), 14.3 (CH3); MS (70 eV, EI) m/z (%) 195 ([M]þ, 100),
174 (9), 153 (5), 109 (15); HRMS (ESIþ) calcd for [C12H22NO]þ
[M þ H]þ 196.1701, found 196.1697; IR (neat) 3220, 1681, 1265,
1250 cm-1; Rf=0.80 (hexane/EtOAc 1:5).
187.0734, found 187.0739; IR (neat) 3370, 1670, 1099, 740 cm-1
;
Rf=0.26 (hexane/EtOAc 3:1).
2-Chloro-3-hydroxy-5-phenylpentanamide (3c). 1H NMR
(300 MHz, CDCl3) δ 7.30-7.20 (m, 7 H), 5.85 (apparent s, 1 H),
5.38-5.30 (m, 1 H), 3.56 (d, J=3.8 Hz, 1 H), 2.90-2.70 (m, 2 H),
2.17-1.95 (m, 2 H); 13C NMR (75 MHz, CDCl3) δ 164.7 (C),
140.4 (C), 128.6 (2ꢀCH), 128.4 (2ꢀCH), 126.3 (CH), 74.8 (CH),
65.9 (CH), 36.3 (CH2), 30.7 (CH2); MS (70 eV, EI) m/z (%)
174 ([Mþ - Cl - H2O], 2), 131 (100), 103 (27), 77 (10); HRMS
(70 eV) calcd for [C11H14ClNO2 - Cl - H2O] 174.0919, found
174.0926; IR (neat) 3352, 1675, 1109, 766, cm-1; Rf = 0.39
(hexane/EtOAc 3:1).
Synthesis of (E)-r,β-Unsaturated Amides (4). To a stirred
suspension of aldehyde 1 (0.4 mmol), dichloroacetamide 2
(0.4 mmol), and samarium powder (2.4 mmol) in THF (25 mL)
was added CH2I2 (2.4 mmol) dropwise at room temperature.
After the mixture stirred vigorously for 12 h, the excess of SmI2
was removed by bubbling a stream of air through the solution.
The crude reaction material was washed with 0.1 N (aq) HCl
(10 mL) and was extracted with dichloromethane (3ꢀ10 mL).
The combined organic layers were dried over anhydrous Na2SO4,
1
Supporting Information Available: Copies of H and 13C
NMR spectra for compounds 3 and 4. This material is available
J. Org. Chem. Vol. 75, No. 10, 2010 3453